SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 85 filers reported holding SCHOLAR ROCK HLDG CORP in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,439,902 | +160.3% | 2,033,789 | +176.5% | 0.31% | +204.0% |
| Q2 2023 | $5,546,763 | +34.6% | 735,645 | +42.8% | 0.10% | +24.7% |
| Q1 2023 | $4,120,000 | -48.2% | 515,000 | -41.4% | 0.08% | -46.7% |
| Q4 2022 | $7,954,977 | +71.9% | 879,003 | +31.6% | 0.15% | +76.7% |
| Q3 2022 | $4,629,000 | -21.7% | 667,943 | -38.0% | 0.09% | -19.6% |
| Q2 2022 | $5,910,000 | – | 1,076,540 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |